SACROCOCCYGEAL TERATOMA IN SWEDEN - A 10-YEAR NATIONAL RETROSPECTIVE STUDY

被引:33
作者
HAVRANEK, P
RUBENSON, A
GUTH, D
FRENCKNER, B
OLSEN, L
KORNFALT, SA
HANSSON, G
机构
[1] GOTHENBURG UNIV,OSTRA HOSP,DEPT PEDIAT SURG,S-41685 GOTHENBURG,SWEDEN
[2] GOTHENBURG UNIV,OSTRA HOSP,DEPT PATHOL,S-41685 GOTHENBURG,SWEDEN
[3] UNIV STOCKHOLM,ST GORANS HOSP,DEPT PEDIAT SURG,S-10691 STOCKHOLM,SWEDEN
[4] UNIV UPPSALA,ACAD HOSP,DEPT PEDIAT SURG,S-75105 UPPSALA,SWEDEN
[5] UNIV LUND HOSP,DEPT PEDIAT SURG,S-22185 LUND,SWEDEN
关键词
SACROCOCCYGEAL TERATOMA; YOLK SAC TUMOR; ALPHA-FETOPROTEIN;
D O I
10.1016/0022-3468(92)90197-F
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Thirty-two children with sacrococcygeal teratoma have been treated during the last 10 years (1980 to 1989) in Sweden. A retrospective study was performed in four departments of pediatric surgery that treat sacrococcygeal teratomas in children from the whole of Sweden. Prenatal and perinatal histories were reviewed together with interval to diagnosis, Altman classification, histology, and serum α-fetoprotein. Details of surgical management ± adjuvant chemotherapy and outcome of patients were also documented. In 8 patients the teratoma was diagnosed prenatally by ultrasonography and there was one postoperative death in this group. Multiagent chemotherapy was used in all but one of 11 patients with malignant teratomas (in 8 of them a cisplatin, bleomycin, vinblastine combination). Only one patient with a malignant tumor treated by single-agent chemotherapy died, 8 others were still alive and tumor-free after 1 to 9 years (mean time, 5.4 years). Two patients developed late relapses and were treated by surgical resection. Metastases occurred in five of the 11 malignant tumors, one at presentation and in four patients 10 to 29 months following surgery. All relapses had distant metastases as well as local disease. Serum α-fetoprotein was used in monitoring some of these patients. © 1992.
引用
收藏
页码:1447 / 1450
页数:4
相关论文
共 14 条
[1]  
ALTER DN, 1988, OBSTET GYNECOL, V71, P978
[2]  
ALTMAN RP, 1974, J PEDIATR SURG, V9, P389
[3]   EFFECTIVE CHEMOTHERAPY FOR METASTATIC MALIGNANT SACROCOCCYGEAL TUMOR [J].
BEDDIS, IR ;
NOBLETT, H ;
MOTT, MG .
MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (04) :231-232
[4]   TERATOMAS IN CHILDHOOD - ANALYSIS OF 142 CASES [J].
BILLMIRE, DF ;
GROSFELD, JL .
JOURNAL OF PEDIATRIC SURGERY, 1986, 21 (06) :548-551
[5]   SACROCOCCYGEAL TERATOMA - HAS CHEMOTHERAPY IMPROVED SURVIVAL [J].
DEWAN, PA ;
DAVIDSON, PM ;
CAMPBELL, PE ;
TIEDEMANN, K ;
JONES, PG .
JOURNAL OF PEDIATRIC SURGERY, 1987, 22 (03) :274-277
[6]   MALIGNANT SACROCOCCYGEAL TERATOMA - ENDODERMAL SINUS, YOLK-SAC TUMOR - IN INFANTS AND CHILDREN - A 32-YEAR REVIEW [J].
EIN, SH ;
MANCER, K ;
ADEYEMI, SD .
JOURNAL OF PEDIATRIC SURGERY, 1985, 20 (05) :473-477
[7]   FETAL SACROCOCCYGEAL TERATOMA [J].
FLAKE, AW ;
HARRISON, MR ;
ADZICK, NS ;
LABERGE, JM ;
WARSOF, SL .
JOURNAL OF PEDIATRIC SURGERY, 1986, 21 (07) :563-566
[8]  
GRISONI ER, 1988, PEDIATR SURG INT, V3, P173
[9]  
JOHNSON JWC, 1988, OBSTET GYNECOL, V71, P981
[10]  
SHANBHOGUE LKR, 1990, PEDIATR SURG INT, V5, P41